Profile data is unavailable for this security.
About the company
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
- Revenue in GBP (TTM)30.80m
- Net income in GBP-21.70m
- Incorporated2016
- Employees279.00
- LocationCreo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
- Phone+44 12 9160 6005
- Websitehttps://creomedical.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Belluscura PLC | 946.97k | -7.88m |
SDI Group PLC | 68.07m | 1.61m |
Inspecs Group PLC | 203.29m | -997.00k |
Creo Medical Group PLC | 30.80m | -21.70m |
Tristel Plc | 39.49m | 6.04m |
Avon Protection PLC | 191.98m | -12.91m |
Advanced Medical Solutions Group plc | 126.21m | 15.89m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Canaccord Genuity Wealth Ltd.as of 19 Mar 2024 | 39.30m | 10.87% |
M&G Investment Management Ltd.as of 31 Jan 2024 | 33.53m | 9.28% |
Amati Global Investors Ltd.as of 31 Jan 2024 | 15.71m | 4.35% |
Baillie Gifford & Co.as of 31 Dec 2022 | 12.54m | 3.47% |
SVM Asset Management Ltd.as of 30 Jun 2023 | 10.62m | 2.94% |
AXA Investment Managers UK Ltd.as of 31 Dec 2022 | 7.99m | 2.21% |
Chelverton Asset Management Ltd.as of 30 Jun 2023 | 7.50m | 2.08% |
Octopus Investments Ltd.as of 30 Apr 2024 | 3.70m | 1.02% |
Border to Coast Pensions Partnership Ltd.as of 30 Sep 2023 | 3.36m | 0.93% |
BlackRock Investment Management (UK) Ltd.as of 30 Sep 2023 | 2.49m | 0.69% |